Corporate Advisory Board
Not unlike our Medical Advisory Board, our Corporate Advisory Board is replete with some of the top business minds in the healthcare industry. Loaded with experience and savvy, Our Corporate Advisory Board serves as the gateway to ensure that we can continue to work towards our vision and help those affected by cancer.

Daniel J. Arbess
Founder, CEO,
Chief Investment Officer,
Xerion Investments
Chief Investment Officer,
Xerion Investments

Andrew Cone
Chief Revenue Officer,
MultiPlan
MultiPlan

Sujay Kango
CCO,
Acceleron Pharma
Acceleron Pharma

Tom Langan
CEO,
Veradigm
Veradigm

Steve Mackin
SVP, Mercy Health &
President, Mercy Hospital
St. Louis
President, Mercy Hospital
St. Louis

David Shulkin
Former US Secretary
of Veterans Affairs
of Veterans Affairs

Steve Simcox
CEO,
Healthtalker
Healthtalker

Doug Ulman
CEO, Pelotonia,
Former CEO of Livestrong
Former CEO of Livestrong

Douglas Watson
Former Chairman of Dendreon,
Former US CEO of Novartis
Former US CEO of Novartis

Peter Wentworth
HR Consultant